In Alzheimer’s disease, the most common cause of dementia, low levels of the protein amyloid-β and high levels of phosphorylated tau in the cerebrospinal fluid are important biomarkers for diagnosis. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.